Distributions Of All Amounts Of PSE Would Be Regulated Under DEA Rule
This article was originally published in The Tan Sheet
The Drug Enforcement Administration continues developing enforcement tools to implement the Combat Meth Act with a Nov. 20 notice of proposed rulemaking to regulate the distribution of all amounts of pseudoephedrine and phenylpropanolamine
You may also be interested in...
The distribution of all amounts of pseudoephedrine and phenylpropanolamine fall under the Drug Enforcement Administration's enforcement, according to a final rule published July 7 in the Federal Register. The rule, which takes effect Aug. 6, is the latest step in DEA's implementation of the Combat Methamphetamine Epidemic Act. It eliminates the current threshold of 2.2 pounds to trigger DEA's reporting and recordkeeping requirements, according to a July 7 Federal Register notice. DEA says the unregulated distribution of any amount of PSE increases the likelihood the substance could be diverted to use for illicit meth manufacturing. DEA also imposed retail sales limits and tracking requirements under provisions of Combat Meth (1"The Tan Sheet" Nov. 26, 2007)
The Senate passed a bill Feb. 11 that requires distributors of pseudoephedrine-containing OTC drugs to sell only to retailers who verify they comply with the Combat Meth Act or who are registered with the DEA
The first arrest for a violation of the Combat Meth Act's limits on retail purchases of pseudoephedrine-containing drugs occurred in western New York state, where investigators manually compile a database to track PSE sales in their county